ProfileGDS5822 / ILMN_2580636
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 35% 31% 50% 7% 9% 10% 6% 48% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.835
GSM1276600PDAC Late Ablation Control 217.531
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 119.650
GSM1276603PDAC Late Ablation 27.47
GSM1276604PDAC Late Ablation 37.79
GSM1303940PDAC Late Ablation_anti-CTLA4 19.710
GSM1303941PDAC Late Ablation_anti-CTLA4 256
GSM1303942PDAC Late Ablation_anti-CTLA4 324.548